Carlson, Christopher
Université Toulouse III - Paul Sabatier · Inserm · The University of Melbourne · Eli Lilly (United States) · Columbia University Irving Medical Center · Centre Hospitalier Universitaire de Toulouse · Austin Health
3 papers on CoChat
Most cited papers
- Verified
Trial of Solanezumab for Mild Dementia Due to Alzheimer’s Disease
Honig, L. S., Vellas, B., Woodward, M., Boada, M., Bullock, R., Borrie, M., Hager, K., Andreasen, N., Scarpini, E., Liu-Seifert, H., et al. (2018) · New England Journal of Medicine
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 1,049
- Verified
Phase 3 solanezumab trials: Secondary outcomes in mild Alzheimer's disease patients
Siemers, E. R., Sundell, K. L., Carlson, C., Case, M., Sethuraman, G., Liu‐Seifert, H., Dowsett, S. A., Pontecorvo, M. J., Dean, R. A., & Demattos, R. (2016) · Alzheimer's & Dementia
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 370
- Verified
Efficacy and Safety of Atomoxetine in Adolescents with Attention-Deficit/Hyperactivity Disorder and Major Depression
The Atomoxetine ADHD and Comorbid MDD Study Group:, Bangs, M. E., Emslie, G. J., Spencer, T. J., Ramsey, J. L., Carlson, C., Bartky, E. J., Busner, J., Duesenberg, D. A., Harshawat, P., et al. (2007) · Journal of Child and Adolescent Psychopharmacology
Attention Deficit Hyperactivity DisorderChild and Adolescent Psychosocial and Emotional Development
Cited by 103
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free